Skip to main content
Year archive

Henan Lingrui Pharmaceutical Co., Ltd — 2026 filings

All 13 regulatory filings released by Henan Lingrui Pharmaceutical Co., Ltd (600285) in 2026, sourced directly from the official regulator.

13 Filings
2026 Period
2026 filings (13)
Filing Released Lang
羚锐制药第十届董事会第一次会议决议公告
Board/Management Information
2026-05-21 Chinese
羚锐制药2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements
2026-05-20 Chinese
羚锐制药关于选举第十届董事会职工代表董事的公告
Board/Management Information
2026-05-20 Chinese
羚锐制药关于会计师事务所2025年度履职情况评估报告
Audit Report / Information
2026-04-27 Chinese
董事会审计委员会2025年度履职情况报告
Audit Report / Information
2026-04-27 Chinese
羚锐制药审计报告
Audit Report / Information FY 2025
2026-04-27 Chinese
独立董事候选人声明与承诺（王钊）
Board/Management Information
2026-04-27 Chinese
羚锐制药2025年度利润分配方案公告
Notice of Dividend Amount
2026-04-27 Chinese
羚锐制药关于大股东部分股份质押的公告
Capital/Financing Update
2026-03-24 Chinese
羚锐制药关于获得药品注册证书的公告
Regulatory Filings
2026-03-23 Chinese
羚锐制药关于大股东部分股份质押的公告
Capital/Financing Update
2026-03-19 Chinese
羚锐制药董事减持股份结果公告
Director's Dealing
2026-01-14 Chinese
羚锐制药关于大股东部分股份质押的公告
Major Shareholding Notification
2026-01-14 Chinese